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 Inflamed tissue in Crohn’s disease (CD) are continuously producing toxic oxygen 
metabolites leading to cellular injury and apoptosis. Here, we are evaluating the role of 
Mycobacterium avium subspecies paratuberculosis (MAP) in oxidative stress in CD by 
evaluation of lipid peroxidation and antioxidant defense activity. Specifically, we measured 
malondialdehyde (MDA) level and selenium-dependent glutathione peroxidase (GPx) activity in 
the plasma from patients and cattle infected with MAP. The level of MAP antibodies in bovine 
sera was determined by IDEXX kit whereas detection of MAP DNA was performed by IS900-
based nPCR. A total of 42 cattle (21 infected with MAP and 21 healthy controls), 27 CD subjects, 
27 of CD-healthy relatives, 66 subjects with various diseases and 34 non-related healthy subjects 
were investigated. Overall, GPx activity was significantly higher in MAP infected humans 
(0.80941±0.521) versus MAP (-ve) samples (0.42367±0.229 units/ml), P<0.01. Similarly, the 
average of GPx activity in cattle infected with MAP was 1.59±0.65 units/ml compared to 
0.46907±0.28 units/ml in healthy cattle (P<0.01).  Although it was not statistically significant, 
MDA average level was higher in MAP infected human samples versus MAP (-ve) controls 
(1.11±0.185 nmol/ml versus 0.805±0.151 nmol/ml, respectively). Similarly, MDA average level 
in CD samples that are MAP+ (1.703±0.231 nmol/ml) was higher than CD samples that are 
MAP (-ve) (1.429±0.187 nmol/ml). In cattle, MDA average level in MAP infected samples was 
significantly higher at 3.818±0.45 nmol/ml compared to 0.538±0.18 nmol/ml in healthy cattle 
(P<0.01). Clearly, the data demonstrated that MAP infection is associated with oxidative stress 
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CHAPTER ONE: INTRODUCTION 
 
Note: This section has been published in part and the citation link is: Qasem, Ahmad, Ahmad 
Abdel-Aty, Huda Abu-Suwa, and Saleh A. Naser. "Oxidative stress due to Mycobacterium 
avium subspecies paratuberculosis (MAP) infection upregulates selenium-dependent GPx 
activity." Gut pathogens 8, no. 1 (2016): 1. 
 
Mycobacterium avium subspecies paratuberculosis (MAP) is implicated in the etiology 
of multiple diseases including Crohn’s disease (CD) and both type I and type II diabetes mellitus 
(DM) in humans [1][2]. It is also known to be a causative agent of Johne’s disease, a bovine 
disease similar to CD in humans [3]. MAP is an obligate intracellular pathogen, living inside the 
macrophages of the infected host [4]. MAP increases the suitability of the macrophage as a host 
and prevents its own destruction by preventing the acidification of the phagosome [5][6]. This is 
done by preventing the fusion of the lysosome and the phagosome into the phagolysosomal 
complex [5][6]. MAP is also resistant to destruction even in an acidified, mature phagolysosome 
[7]. The primary mechanism for the destruction of MAP resistant to phagolysosomal degradation 
is the induction of apoptosis of the infected macrophage through a tumor necrosis factor α (TNF-
α) dependent mechanism [8][9]. There is evidence that Mycobacteria evade this host response by 
inhibiting apoptosis, and by stimulating necrosis, which allows the bacteria to disseminate 
[10][11]. Furthermore, in an active infection the body’s ability to clear apoptotic cells may be 
outpaced. The delay in clearance results in the apoptotic cell bodies losing their membrane 
integrity and becoming secondary necrotic cells [12]. In the case of the apoptosis of an active 
macrophage, this includes the leaking of lysosomal content. This includes reactive oxygen 
species (ROS), which leads to inflammation and oxidative stress.     
Selenium is an important trace element that has many biological functions, particularly 
through its incorporation into multiple selenoproteins. There are 25 such proteins in humans [13]. 
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One of these proteins is glutathione peroxidase (GPx), an antioxidant enzyme found in all 
eukaryotes. This enzyme uses glutathione to reduce hydrogen peroxide, lipid peroxides, and 
hydroperoxides [14]. Though selenium has been shown to have insulin mimetic properties, 
elevated selenium has been associated with diabetes [15][16][17]. This is possibly due to the 
selenium found in GPx. Elevated GPx, as well as the corresponding elevation in selenium, is 
associated with type I diabetes [18]. GPx has also recently been implicated in the 
pathophysiology of type II diabetes. McClung et al. found that overexpression of GPx in mice 
resulted in the development of hyperinsulinemia, hyperglycemia, and decreased insulin 
sensitivity, all of which are indicators of type II diabetes [19]. Though the mechanism of this is 
poorly understood, they proposed that excessive GPx quenched peroxides too quickly, resulting 
in less ROS-mediated inhibition of protein-tyrosine phosphatases [19]. Inhibition of these 
phosphatases, which dephosphorylate insulin receptors, increases insulin sensitivity [20]. Xi Yan 
et al. found that decreasing selenium intake in mice overexpressing GPx decreases the 
hyperinsulinemia, hyperglycemia, and insulin resistance caused by the elevated GPx expression 
[21]. Excessive dietary selenium, on the other hand, has been found to upregulate GPx and result 
in higher insulin resistance [22][23]. A similar trend was found in humans [24]. Selenoproteins 
are also upregulated as a result of oxidative stress [25]. 
              The inflamed mucosal tissues in Crohn’s disease patients have overactive inflammatory 
cells, which are subsequently producing toxic oxygen metabolites such as hydrogen peroxide and 
nitric oxide leading to impairment of cellular membrane integrity and finally cell death occurs by 
lipid peroxidation [36][37]. Studies have shown that oxidative stress levels are elevated and 
antioxidant defenses are declined in intestinal tissues of patients with inflammatory bowel 
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disease (IBD) [38]. On the other hand, Bhasker et al. did not find any difference in antioxidant 
enzymes activities or lipid peroxidation products in the mucosa of IBD patients and controls [39]. 
 
 The association between MAP infection and oxidative stress is poorly understood. The 
objective in our studies was to assess the potential association between MAP infection and the 
activity of selenium-dependent GPx and quantifying the lipid peroxidation product 
malondialdehyde (MDA) in bovine and human samples. We hypothesize that the oxidative stress 
caused by MAP infection will result in elevated GPx activity and elevate MDA production. The 
oxidative stress associated with MAP infection may be clinically relevant to diseases including 

























CHAPTER TWO: MATERIALS AND METHODS 
 
Note: This section has been published in part and the citation link is: Qasem, Ahmad, Ahmad 
Abdel-Aty, Huda Abu-Suwa, and Saleh A. Naser. "Oxidative stress due to Mycobacterium 
avium subspecies paratuberculosis (MAP) infection upregulates selenium-dependent GPx 




Sera samples from healthy and MAP infected cattle were kindly provided by Dr. Michael 
Collins (University of Wisconsin). Bovine samples were confirmed for MAP infection using the 
IDEXX Mycobacterium paratuberculosis (M. pt.) Antibody Test Kit (IDEXX Laboratories, 
Westbrook, ME, USA) following manufacturer instructions. A S/P less than or equal to 0.60 was 
considered negative and a S/P greater than or equal to 0.70 was considered positive. Sera from 





Human blood samples were collected in two separate sets where each subject provided 
three 6.0-mL K2-EDTA tubes. All clinical samples were collected following Institutional Review 
Board approval. A total of 27 human blood samples were collected from CD patients along with 
27 samples of their healthy biological family members (parents or siblings), those samples were 
collected at the University of Florida (UF). An additional randomized 100 blood samples used in 
earlier studies were also included. Clinical samples were collected blindly with no prior 
knowledge of MAP diagnosis or other health conditions. Buffy coat preparations and plasma 
samples were separated and stored at – 20o C.  
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Table 1: Demographics of Crohn’s patients and healthy relatives. 
Group Age range Average age Gender ratio 
(M/F) 
 
Relatives 12-65 45 9/18 
Crohn’s 16-56 32 8/19 
 
 
DNA extraction and nested PCR analysis 
DNA extraction for PCR analysis was performed on purified buffy coat samples. Each 
sample was re-suspended in 100 μL of TE buffer and then incubated at 100 °C for 30 minutes. 
The re-suspended solution was then placed in an ice bath for 15 minutes, after which it was 
centrifuged for 10 minutes at 4°C at 12,000 rpm (18500 g). After centrifugation, the supernatant 
was extracted in 200 μL of phenol/chloroform/isoamyl alcohol (1:1:24 v/v; Acros Organics, 
Morris Plains, NJ, USA) was added. The solution was mixed and centrifuged for five minutes at 
4°C at 12,000 rpm (18,500g). The pellet, containing the nucleic acid, was then washed, dried, 
and re-suspended in 50 μL of sterile water [3]. 
Detection of MAP DNA using nested PCR (nPCR) was based on the MAP-specific 
IS900 derived oligonucleotide primers [3].  As shown in Table 2, P90 and P91 primers were used 
for the amplification of 398 bp in the first round of amplification and AV1 and AV2 primers, 
were used to amplify a 298 bp internal sequence. Each primary PCR reaction used 10 µL of 
DNA template and 40 µL of PCR buffer, which consists of 5 mM MgCl2, 0.2 mM dNTP, 2 µM 
primers, and 2.5 U Platinum Taq polymerase (Invitrogen, Carlsbad, CA, USA) or 1 U TFL DNA 
polymerase (Promega, Madison, WI, USA). Each secondary round of PCR used the same 
ingredients, except different primers were used and 5 µL of the product of the primary round was 
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used instead of the DNA template. Negative controls for the PCR were prepared in which sterile 
water or TE buffer was added instead of the DNA template (in the primary amplification) or the 
primary product (in the secondary amplification). These negatives were prepared in parallel with 
the samples. Positive controls were also prepared using MAP DNA from strain ATCC 43015. 
The amplification product size was assessed on 2% agarose gel. 
 
Table 2: Primers and amplification conditions used for PCR. 













IS900 95°C for 5 min, 
then 34 cycles of 
95°C for 1 min, 
58°C for 1.5 min, 
72°C for 1.5 min. 
Final extension of 
10 min at 72°C. 










IS900 95°C for 5 min, 
then 34 cycles of 
95°C for 1 min, 
58°C for 1.5 min, 
72°C for 1.5 min. 
Final extension of 
10 min at 72°C. 







Selenium-dependent Glutathione Peroxidase (Gpx) activity measurement 
 
 Glutathione peroxidase works by reducing peroxides by oxidizing glutathione. The 
glutathione is then restored for further cycles of catalysis (Figure 1). The selenium-dependent 
glutathione peroxidase activity was measured by using the Sigma-Aldrich Glutathione 
Peroxidase Cellular Activity Assay Kit (Sigma-Aldrich, St. Louis, MO, USA). Glutathione 
peroxidase works by reducing peroxides by oxidizing glutathione. The glutathione is then 
restored for further cycles of catalysis (Figure 1). The rate-limiting step of this reaction is that in 
which the oxidized glutathione used to reduce the peroxide is restored via the oxidation of 
NADPH. NADPH absorbs at 340 nanometers, the decrease in absorbance over time is 
determinative of the activity of serum glutathione peroxidase. Tert-butyl hydroperoxide in 
particular was used because its breakdown depends specifically on selenium-containing 
glutathione peroxidase.  
 
All reagents were brought to room temperature before beginning the assay. The NADPH 
was resuspended with sterile water. The glutathione peroxidase standard was re-suspended with 
assay buffer. A blank was made using 940 µL of assay buffer, 50 µL of NADPH, and 10 µL of 
tert-butyl peroxide, so that the uncatalyzed breakdown of NADPH could be subtracted from the 
catalyzed rate. Standards containing 0.05 and 0.125 units of enzyme were made as positive 
controls to ensure the assay was working. For each sample 930 µL of buffer, 50 µL of NADPH, 
and 10 µL of sample were mixed. 10 µL of t-butyl hydroperoxide were added last, since its 
addition initiated the reaction. The absorbance at 340 nm was measured over the course of a 
minute.  
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The activity was determined according to the following equation provided by the 
manufacturer, derived from Beer’s Law: 
Activity =
Δ Absorbance ∗ Dilution Factor
6.22 ∗  Volume of sample
  
Where 6.22 is the extinction coefficient of NADPH in mL*mmol-1*cm-1 and 
ΔAbsorbance is the change in absorbance at 340 nm over the course of one minute, not including 
the natural rate of NADPH degradation. 
 
Quantification of Lipid Peroxidation product (MDA) 
 
          Lipid peroxidation forms malondialdehyde (MDA) and 4-hydroxynonel (4-HNE), as 
natural biproducts. Measuring MDA in plasma or body tissues is a useful indication of oxidative 
damage. MDA quantification was done by using Lipid Peroxidation Colorimetric/Fluorometric 
Assay Kit (BioVision, Milpitas, CA, USA). This test is known as TBARS assay. 10uL of plasma 
was mixed with 500uL H2SO4 in a microcentrifuge tube. 125uL of Phosphotungstic acid solution 
was added into each tube and vortexed. After 5 minutes of incubation, the tubes were centrifuged 
for 3 minutes at 13,000 X g. The pellet was collected and resuspended on ice with 2uL of 
Butylated hydroxytoluene (BHT 100X). Final volume was adjusted to 200uL with ddH2O. 
Standards with different concentrations were prepared from MDA standard solution (4.17M). 
600uL of Thiobarbituric Acid (TBA) was added into each tube to generate the MDA-TBA 
adduct. Tubes were incubated at 95oC for 60 min then cooled down in an ice bath for 10 minutes. 
200uL from each reaction 800uL mixture were pipetted into 96-well microplate for analysis. The 
MDA-TBA adduct was quantified colormetrically (OD 532 nm) by reading absorbance. MDA 
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standard curve was generated and used to determine the MDA amount in each test sample in 























CHAPTER THREE: RESULTS 
 
Note: This section has been published in part and the citation link is: Qasem, Ahmad, Ahmad 
Abdel-Aty, Huda Abu-Suwa, and Saleh A. Naser. "Oxidative stress due to Mycobacterium 
avium subspecies paratuberculosis (MAP) infection upregulates selenium-dependent GPx 
activity." Gut pathogens 8, no. 1 (2016): 1. 
 
MAP Prevalence in Human Samples 
 
 We performed nPCR on DNA extracts isolated from all human blood samples in order to 
analyze for the presence of MAP-specific IS900 gene according to Naser et al. protocol [3]. The 
overall prevalence of MAP among 154 human blood samples was 32%. MAP was positive in the 
blood of 40% of CD patients compared to 29.9% in non-CD patients. Specifically MAP was also 
positive in 11/27 (40%) of CD patients and in 2/27 (7%) in healthy biological family members. 
Interestingly, 33% (7 out of 21) of patients with type II diabetes and 44% (7 out of 16) pre-
diabetic patients were also MAP positive. Patients were considered to be pre-diabetic if they had 
a fasting blood sugar level between 100 and 125 mg/dl, if the two-hour glucose levels was 
between 140 and 199 mg/dl in an oral glucose tolerance test, or if they had a glycated 
hemoglobin (A1C) level between 5.7 and 6.4. Figure 3 illustrates the detection of MAP IS900 
gene on 2% agarose gel following nPCR analysis of 100 randomized human blood samples 
(lanes 1 to 100). 
 
Selenium-dependent GPx levels were elevated in MAP infected bovine samples 
 
          Bovine sera were confirmed for presence of anti-MAP IgG. Consequently, a total of 21 
cattle sera samples from animals diagnosed with Johne’s disease (MAP positive) and 21 sera 
from healthy cattle (MAP negative) were selected for the study. All 42 sera were analyzed for of 
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GPx activity. The average level of GPx was 0.46907±0.28 units/ml in healthy cattle sera control 
compared to 1.590±0.65 units/ml in sera from cows infected with MAP, where a unit was 
defined as one mmol/minute. The MAP positive samples had a significantly higher activity level, 
with a difference in means of 1.122 (95% confidence interval 0.810 to 1.435; P < 0.01) [Table 3]. 
Figure 4a shows a scatter plot of selenium-dependent GPx activity for MAP negative and MAP 
positive samples. 
 
Selenium-dependent GPx activity was elevated in MAP infected humans among Crohn’s 
patients and their healthy relatives  
 
         The average level of GPx activity was 0.80941±0.521 units/ml in the MAP positive 
samples, while the average enzyme activity in MAP negative samples was found to be 
0.42367±0.229 units/ml. This result reveals that MAP infection has a significant influence on 
GPx activity, with a difference in means of 0.387 (95% confidence interval 0.182 to 0.592; P < 
0.01) [Figure 4b].  
 
The difference between selenium-dependent GPx activity in Crohn’s Disease and in 
Healthy individuals was not significant 
 
           In order to confirm that the elevation of GPx activity level was due to MAP infection 
alone, and not due to CD status, we measured the average of GPx activity in healthy individuals 
and CD patients separately. The average GPx activity was found to be 0.54±0.414 units/ml and 
0.493±0.301 units/ml in CD and healthy patients respectively. While the mean GPx enzymatic 
activity in CD patients was higher by 0.0469, our results showed that there was no significant 






Selenium-dependent GPx activity was elevated in MAP infected Crohn’s patients: 
 
          As mentioned earlier, out of 27 CD patients, a total of 11 were tested as MAP positive, 
while 16 were MAP negative. The average GPx activity in CD patients who had the MAP 
infection was 0.7593±0.537 units/ml, while the GPx activity was found to be 0.389±0.213 
units/ml in CD patients without MAP infection. The difference in means was 0.37 (95% 
confidence interval 0.07 to 0.675; P = 0.019). (P value = 0.019) [Figure 4d]. Furthermore only 2 
of the 27 healthy relatives used as controls, or 7.4%, were infected with MAP.  
 
Selenium-dependent GPx activity was elevated among MAP infected humans in 
randomized field study 
 
 Among randomized blood samples from 100 subjects, 36 were determined to be MAP 
positive as shown in Figure 3. The average of GPx activity level in 36 MAP positive clinical 
samples was 0.6510±00.1665 units/ml compared 0.4702±0.1299 in 64 MAP negative clinical 
samples (P < 0.01) [Table 3]. The GPx activity in each clinical sample is illustrated in Figure 4E. 
We further examined the difference in GPx activity according to disease diagnosis, but there was 
no significant difference in MAP negative clinical samples between healthy controls and subjects 
with diseases.  
It is notable, however, that in all disease states MAP positive individuals still have higher 
enzymatic activity than MAP negative individuals [Figure 5].  
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(Units/ml)                                        
P value 
21/42 Bovine Negative 0.469±0.28 P< 0.01 
21/42 Bovine Positive 1.590±0.65  
105/154 Human  Negative 0.452±0.176 P< 0.01 
49/154 Human  Positive 0.693±0.30  
16/27 CD Patients Negative 0.389±0.213 P<0.05 
11/27 CD Patients Positive 0.7593±0.537  
 
MDA levels are significantly elevated in MAP infected bovine samples 
 
          Sera from 21 cattle infected with MAP and 21 healthy cattle were analyzed for the level of 
MDA. The average level of MDA was 0.538±0.18 nmol/ml in healthy cattle sera control 
compared to 3.818±0.45 nmol/ml in sera from cows infected with MAP. The MAP positive 
samples had a significantly higher MDA level (P < 0.05) [Figure 6]. This result shows higher 
level of lipid peroxidation in cattle infected with MAP. 
 
MDA levels are elevated in Crohn’s patients: 
          The average level of MDA in MAP positive CD patients was 1.703±0.231 nmol/ml, while 
the average MDA level in MAP negative CD patients was found to be 1.429±0.187 nmol/ml. 
The MDA average level in the healthy relatives was 0.527±0.158 nmol/ml. This shows 
significant elevation of lipid peroxidation in CD patients in comparison to healthy subjects (P < 
0.05). However there was no significant difference (P > 0.05) among CD patients according to 
MAP 
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Infection but it is still slightly elevated in MAP positive samples [Figure 6]. We also included 20 
healthy controls in this study and we found MDA average level to be 0.562 nmol/ml. Table 4 
illustrates the average MDA level between different group sets. 
 
Table 4: MDA Average level in Bovine and Human Samples. 
Number of 
Samples 







21 Bovine Johne’s/MAP + 3.818±0.451 P < 0.05 
21 Bovine Johne’s/MAP - 0.538±0.182  
11 Human CD/MAP + 1.703±0.231 P > 0.05 
16 Human CD/MAP - 1.429±0.187  
35 Human Healthy/MAP - 0.521±0.135 P > 0.05 





















CHAPTER FOUR: DISCUSSION 
 
Note: This section has been published in part and the citation link is: Qasem, Ahmad, Ahmad 
Abdel-Aty, Huda Abu-Suwa, and Saleh A. Naser. "Oxidative stress due to Mycobacterium 
avium subspecies paratuberculosis (MAP) infection upregulates selenium-dependent GPx 
activity." Gut pathogens 8, no. 1 (2016): 1. 
 
Oxidative stress and the resulting GPx up-regulation may have significant implications 
on disease pathophysiology. In particular, long-term up-regulation of GPx may cause insulin 
resistance and disruptions in insulin signaling [19]. Furthermore, oxidative damage has recently 
been an area of focus for research into inflammatory conditions such as CD and inflammatory 
bowel disease (IBD). Despite this, the relationship between MAP infection and oxidative stress 
has not been clearly established. The purpose of our study was therefore to elucidate the 
relationship between MAP infection and GPx activity in plasma. This makes it possible to find 
the differences in oxidative stress level in CD patients with the presence and absence of MAP 
infection, which may have implications on the treatment of these patients. We acquired bovine 
and human samples, tested them for MAP infection, and measured their GPx activity. 
We found that the enzymatic activity of GPx was significantly higher in cows as well as 
among two separate groups of human subjects that are infected with MAP, where significance 
was defined as P<0.05. This matched the expected trend. We chose to keep the data for the two 
cohorts of human patients separate, as the samples for these two groups were collected separately 
and for different reasons. The CD patients and their healthy relatives were used primarily to 
determine if the observed trend was caused by CD status, or if it was caused by MAP infection. 
We propose to exclude CD as a potential cause of the observed trend due to the previously 
established relationship between MAP and CD [1][3][26-29]. The biological relationships 
present in this group was ideal for determining the effects of CD, as any observable difference in 
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GPx activity could be attributed to the disease status, rather than hereditary environmental 
factors. However, in determining the effect of MAP on GPx activity, we determined that a 
randomized study would be preferable, and would better reflect the prevalence of MAP in 
subjects at large. It is worth noting, however, that when all human clinical samples were 
combined, MAP positive samples still had significantly elevated GPx activity when compared to 
MAP negative samples (P < 0.01).  
We found that there was there no significant difference in GPx activity in MAP negative 
samples from CD and non-CD samples.  However, GPx activity was elevated in all clinical 
samples which were positive for MAP regardless of the source of samples. While it was 
surprising that an inflammatory condition like CD has no significant effect on GPx, this makes a 
stronger case that MAP infection may be playing a role in the elevation in enzymatic activity. 
We further excluded CD status as a potential confounding factor in the human samples by 
comparing CD patients infected with MAP with those not infected with MAP. We found that 
there was still a significant correlation between MAP infection and GPx even when CD status 
was controlled for (P<0.05). 
The prevalence of MAP in CD patients was 40% compared to 7.4% MAP in healthy 
relatives (P < 0.01), indicating that the CD patients were more susceptible to MAP infection. 
This is consistent with published reports [3, 26-28, 30-32]. This study is the first to investigate 
the association of MAP and CD did using healthy relatives as controls. Our findings strengthen 
the growing body of literature supporting the correlation between MAP and CD.  Of course the 
role of MAP in CD etiology remains debated but genetic susceptibility especially single 
nucleotide polymorphism in key genes in patients with CD may promote MAP infection [3, 30-
32]. 
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The pathogenesis mechanism of CD involves interaction between environmental agents, 
genetic and immunologic abnormalities [33]. Recently, the role of reactive oxygen species has 
been an area of interest to study IBD pathophysiology [34]. Granulocyte accumulation is 
increased in the gut mucosa where inflammation is active in IBD patients and those cells secrete 
different inflammatory mediators [33]. It has been shown that mucosal inflammation impairs 
antioxidant defense and the tissues become more liable to oxidative damage [35]. Increasing GPx 
antioxidant activity is a result of elevation in free radical levels. It is unknown if granulocyte 
accumulation is increased in CD patients who are infected with MAP in comparison to CD 
patients who are not. This will lead to different phenotypes of CD patients who are MAP positive 
or negative with differences in oxidative stress and free radical levels in according to the disease 
state which will be reflected in the clinical status of those patients. 
We also considered smoking, gender, and age as potential confounding factors. There 
was no significant difference in GPx activity between males and females or smoking habits. The 
GPx enzymatic activity of patients above 40 was overall lower, but the difference was not 
significant. None of these factors proved to have an effect on our data. 
            None of the studies took MAP infection status into consideration when they measured 
lipid peroxidation or antioxidant enzymes in CD patients. MAP infection causes systemic 
inflammation and oxidative stress. It is possible that free radicals production is up-regulated after 
MAP infection. This will be reflected in elevation of lipid peroxides level including MDA. 
           In our studies we found significant elevation of MDA level in bovine sera infected with 
MAP in comparison to healthy ones. We chose bovine as our animal model since Johne’s disease 
shares very similar signs and symptoms to CD in humans. In addition to that, there are less 
confounding factors in bovine samples, as they are fed with a similar diet and they are living in 
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similar conditions, as opposed to humans in which these factors might vary widely. Thus, cows 
may be considered a pure model for CD and MAP studies, and the results from the bovine 
samples may be more representative than human ones. MAP is also under extensive investigation 
as a causative agent of CD in humans. Elevation of lipid peroxides is an indication of oxidative 
stress. 
We measured MDA level in plasma of 27 CD patients with both MAP positive and 
negative status. MDA level was significantly elevated in those patients (P < 0.05) when we 
compared them to their 27 healthy biological relatives and 20 healthy nonrelated controls. 
Despite this fact, MDA in CD patients was still within normal range (< 2 nmol/ml) which could 
be justified as lipid peroxidation in those patients is contained. This might be due to medications 
that CD are continuously taking such as sulfasalazine which works as free radicals scavenger. 
We did not find any significant difference in MDA level between CD patients when MAP status 
was considered as a factor. However, MDA was slightly elevated in CD patients infected with 
MAP (P > 0.05). 
 While significant in both human and bovine samples, the difference in average GPx 
activity between MAP infected and non-infected samples was much more extreme in the bovine 
samples. This is possibly because bovine are capable of a more robust response, or because they 
have a larger bacterial load, than humans. There are also less confounding factors in bovine 
samples, as cattle used as livestock are fed similar diets and live in similar conditions, as opposed 
to humans in which these factors vary widely. As such, cows may be a purer model for study, 
and the results from the bovine samples may be more representative.  
 The unique progression of MAP infection causes systemic inflammation and oxidative 
stress. It is possible that GPx production is up-regulated in order to compensate for this. Though 
 19 
on the short term this may offset the negative effects of the infection, on the long term, 
particularly in chronic infections, it may cause its own problems. Future studies will further 
elucidate the relationship between MAP infection, GPx up-regulation, glucose homeostasis, as 





















CHAPTER FIVE: CONCLUSION 
 
           The enzymatic activity of selenium dependent glutathione peroxidase was significantly 
higher in both bovine and human serum samples infected with MAP. We hypothesize that the 
presence of this bacterium causes systemic inflammation and oxidative stress, which on the long-
term may cause disruptions in insulin signaling and have a deleterious effect on insulin 
sensitivity. [40] 
          Lipid peroxidation level, which is characterized by measuring MDA in plasma, was 
significantly higher in both bovine infected with MAP and CD patients. During this process, 
MAP infection could be involved in the pathophysiology of worsening the condition of CD 
patients who are MAP positive when we compare them to MAP negative CD patients. Future 
studies need to be done on intestinal mucosal tissues of CD patients to confirm the presence of 





























































Figure 3: Agarose gels illustrating the presence or absence of MAP-IS900 gene following nPCR.  
  The PCR products following the second round of nPCR were analyzed on 2% agarose gel. (M): 
represents molecular weight marker in bp. (=): represents negative control from second round of 
amplification. (-): represents negative control from first round of amplification. (TE): represents 
TE buffer negative control. (+): represents positive control prepared from MAP DNA strain 





Figure 4: Scatter plot of selenium-dependent GPx activity for all MAP negative and MAP 











Figure 5: Average GPx activity levels in plasma samples from blood samples identified as MAP 







Figure 6: Average MDA levels of MAP negative and positive in human and bovine samples to 
according to disease status. 
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Table 5: GPx Enzyme Activity, MDA level and MAP presence in Bovine Samples.   
Sample 
 




N1 Negative 0.635 0.714266 
N2 Negative 0.485 0.585686 
N3 Negative 0.423 0.377979 
N4 Negative 0.356 0.38787 
N5 Negative 0.069 0.714266 
N6 Negative 0.858 0.961536 
N7 Negative 0.641 0.585686 
N8 Negative 0.562 0.526341 
N9 Negative 0.454 0.526341 
N10 Negative 0.392 0.437324 
N11 Negative 0.167 0.565904 
N12 Negative 0.361 0.526341 
N13 Negative 0.467 0.50656 
N14 Negative 0.262 0.417542 
N15 Negative 0.255 0.437324 
N16 Negative 0.367 0.496669 
N17 Negative 0.362 0.486778 
N19 Negative 0.352 0.437324 
N20 Negative 0.310 0.51645 
N30 Negative 1.392 0.397761 
N35 Negative 0.673 0.556014 
P2 Positive 1.200 5.906936 
P3 Positive 2.233 2.069306 
P5 Positive 0.745 2.306685 
P6 Positive 1.295 1.673674 
P8 Positive 1.059 1.060444 
P9 Positive 1.927 5.916827 
P15 Positive 1.329 2.207777 
P16 Positive 2.127 2.821007 
P22 Positive 0.668 0.694485 
P24 Positive 0.916 2.277013 
P25 Positive 0.588 0.931864 
P33 Positive 1.406 0.714266 
P38 Positive 1.813 2.999041 
P39 Positive 1.670 3.384782 








P43 Positive 2.575 4.898075 
P44 Positive 1.553 7.479574 
P45 Positive 3.290 4.779385 
P46 Positive 1.847 4.255173 
P49 Positive 1.740 3.493581 





Table 6: Age, GPx Enzyme Activity, MDA level, Diagnosis and MAP infection in Crohn’s 
Patients and their healthy relatives. 
Sample Diagnosis Age MAP diagnosis 




BF147 Healthy 12 Negative 0.40 0.692 
BF156 Healthy 25 Negative 0.90 0.521 
BF139 Healthy 28 Negative 0.25 0.568 
BF135 Healthy 23 Negative 0.38 0.217 
BF163 Healthy 31 Negative 0.456 0.189 
BF136 Healthy 31 Negative 0.78 0.513 
BF149 Healthy 32 Negative 0.69 0.642 
BF154 Healthy 46 Negative 0.37 0.439 
BF123 Healthy 48 Negative 0.289 0.385 
BF150 Healthy 49 Negative 0.436 0.472 
BF158 Healthy 42 Negative 0.497 0.593 
BF141 Healthy 59 Negative 0.452 0.233 
BF125 Healthy 55 Negative 0.163 0.739 
BF126 Healthy 55 Negative 0.289 0.652 
BF131 Healthy 57 Negative 0.174 0.581 
BF175 Healthy 59 Negative 0.19 0.539 
BF134 Healthy 57 Negative 0.315 0.483 
BF129 Healthy 61 Negative 0.293 0.591 
BF116 Healthy 65 Negative 1.06 0.171 
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BF165 Healthy 62 Negative 0.449 0.647 
BF140 Healthy 61 Negative 0.10 0.545 
BF128 Healthy N/A Negative 0.39 0.513 
BF148 Healthy N/A Negative 0.66 0.637 
BF109 Healthy N/A Negative 0.383 0.478 
BF159 Healthy 24 Positive 1.40 0.753 
BF155 Healthy 40 Positive 0.779 0.672 
BF105 Crohn's 19 Negative 0.307 1.147 
BF151 Crohn's 16 Negative 0.417 1.492 
BF160 Crohn's 18 Negative 0.782 1.389 
BF144 Crohn's 19 Negative 0.21 1.423 
BF142 Crohn's 28 Negative 0.412 1.336 
BF161 Crohn's 27 Negative 0.123 1.421 
BF117 Crohn's 31 Negative 0.12 1.548 
BF108 Crohn's 34 Negative 0.606 1.587 
BF121 Crohn's 33 Negative 0.126 1.563 
BF111 Crohn's 33 Negative 0.489 1.237 
BF157 Crohn's 43 Negative 0.225 1.531 
BF112 Crohn's 51 Negative 0.235 1.592 
BF133 Crohn's 56 Negative 0.442 1.283 
BF127 Crohn's N/A Negative 0.473 1.356 
BF113 Crohn's N/A Negative 0.487 1.475 
BF114 Crohn's N/A Negative 0.77 1.492 
BF143 Crohn's 19 Positive 0.948 1.852 
BF124 Crohn's 20 Positive 1.00 1.741 
BF122 Crohn's 20 Positive 0.354 1.344 
BF137 Crohn's 35 Positive 1.25 1.471 
BF101 Crohn's 32 Positive 0.902 1.905 
BF102 Crohn's 38 Positive 0.12 1.656 
BF103 Crohn's 44 Positive 0.394 1.703 
BF107 Crohn's 44 Positive 0.535 1.846 
BF130 Crohn's 52 Positive 0.5 1.466 
BF100 Crohn's N/A Positive 2.00 1.812 
BF110 Crohn's N/A Positive 0.35 1.941 
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Table 7: Age, GPx Enzyme Activity, Diagnosis and MAP infection in field study. 
Sample Diagnosis Age MAP 
Diagnosis 
GPx Activity 
(Units/ml)   
                                      
Sample 1 Healthy 54 Positive 0.5635 
Sample 2 Healthy 20 Positive 0.6185 
Sample 3 Anxiety, Migraine 46 Negative 0.4625 
Sample 4 Pre-diabetes 46 Negative 0.2750 
Sample 5 Anemia 47 Negative 0.4200 
    Sample 6 Thyroid disease 20 Positive 0.6525 
Sample 7 Migraine 22 Negative 0.4315 
Sample 8 Diabetes Type II, Migraine 63 Negative 0.5900 
Sample 9 Diabetes Type II 38 Positive 0.4335 
Sample 10 Lung cancer 74 Positive 0.4410 
Sample 11 Pre-diabetes 23 Positive 0.7630 
    Sample 12 Thyroid disease 20 Negative 0.3720 
Sample 13 Anemia 31 Positive 0.7800 
Sample 14 Anemia 76 Negative 0.5205 
Sample 15 Anemia 43 Negative 0.6950 
Sample 16 Diabetes Type II 45 Positive 0.4945 
Sample 17 Diabetes Type II 38 Negative 0.4135 
Sample 18 Diabetes Type II 61 Positive 0.5215 
Sample 19 Diabetes Type II 60 Negative 0.6145 
Sample 20 Diabetes Type II 63 Positive 0.5440 
Sample 21 Diabetes Type II 57 Positive 0.6515 
Sample 22 Diabetes Type II 74 Positive 0.6270 
Sample 23 Diabetes Type II 43 Negative 0.5820 
Sample 24 Diabetes Type II 80 Positive 0.6635 
Sample 25 Diabetes Type II 60 Negative 0.4515 
Sample 26 Diabetes Type II 63 Negative 0.4500 
Sample 27 Diabetes Type II 51 Negative 0.6615 
Sample 28 Diabetes Type II 57 Negative 0.5285 
Sample 29 Diabetes Type II 63 Negative 0.2900 
Sample 30 Diabetes Type II 44 Negative 0.8045 
Sample 31 Diabetes Type II 59 Negative 0.4070 
Sample 32 Diabetes Type II 43 Negative 0.4215 
Sample 33 Diabetes Type II 55 Negative 0.6810 
Sample 34 Esophageal cancer 69 Negative 0.3080 
Sample 35 Fatty liver  31 Negative 0.4380 
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Sample Diagnosis Age MAP 
Diagnosis 
GPx Activity 
(Units/ml)   
                                      
Sample 36 Healthy 28 Negative 0.5000 
Sample 37 Healthy 49 Negative 0.1955 
Sample 38 Diabetes Type II, Myositis 65 Positive 0.7105 
Sample 39 Healthy 16 Negative 0.2315 
Sample 40 Healthy 62 Negative 0.3105 
Sample 41 Healthy 14 Negative 0.3925 
Sample 42 Healthy 47 Negative 0.4550 
Sample 43 Healthy 31 Negative 0.1790 
Sample 44 Healthy 51 Negative 0.4710 
Sample 45 Gout 61 Positive 0.8505 
Sample 46 Healthy 49 Positive 0.5140 
Sample 47 Healthy 19 Negative 0.3985 
Sample 48 Healthy 44 Negative 0.4480 
Sample 49 Healthy 21 Positive 0.6125 
Sample 50 Urinary Tract Infection 20 Positive 0.5700 
Sample 51 Healthy 52 Positive 0.5360 
Sample 52 Healthy 45 Negative 0.4185 
Sample 53 Healthy 27 Positive 0.7780 
Sample 54 Healthy 24 Negative 0.4120 
Sample 55 Healthy 62 Negative 0.6700 
Sample 56 Healthy 77 Negative 0.5405 
Sample 57 Healthy 20 Positive 0.7345 
Sample 58 Healthy 30 Positive 0.7435 
Sample 59 Healthy 26 Negative 0.4760 
Sample 60 Healthy 43 Negative 0.7685 
Sample 61 Healthy 52 Positive 0.4905 
Sample 62 Healthy 25 Positive 0.4455 
Sample 63 Healthy 54 Negative 0.4755 
Sample 64 Healthy 51 Negative 0.6350 
Sample 65 Healthy 45 Positive 0.7620 
Sample 66 Healthy 84 Positive 0.7275 
    Sample 67 Thyroid disease 37 Negative 0.3770 
Sample 68 Healthy 62 Positive 0.6675 
Sample 69 Healthy 41 Negative 0.5195 
Sample 70 Myositis 52 Positive 0.5940 
Sample 71 Healthy 53 Negative 0.6600 
Sample 72 Healthy 53 Negative 0.4650 
Sample 73 Thyroid disease 19 Negative 0.4770 
Sample 74 Healthy 25 Negative 0.4520 
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Sample Diagnosis Age MAP 
Diagnosis 
GPx Activity 
(Units/ml)   
                                      
Sample 75 IBS 46 Negative 0.4950 
Sample 76 Myositis 44 Negative 0.5800 
Sample 77 Pre-diabetes 72 Negative 0.5180 
Sample 78 Pre-diabetes 70 Negative 0.3170 
Sample 79 Pre-diabetes 38 Negative 0.4685 
Sample 80 Pre-diabetes 53 Negative 0.4430 
Sample 81 Healthy 20 Negative 0.4125 
Sample 82 Pre-diabetes 23 Negative 0.6805 
Sample 83 Pre-diabetes 68 Negative 0.5375 
Sample 84 Pre-diabetes, Myositis 30 Negative 0.4195 
Sample 85 Rheumatoid arthritis, Pre-diabetes 55 Negative 0.3745 
Sample 86 Thyroid Disease 32 Negative 0.5170 
Sample 87 Pre-diabetes  37 Positive 0.8805 
Sample 88 Thyroid disease 59 Negative 0.4275 
Sample 89 Pre-diabetes 49 Positive 0.8330 
Sample 90 Thyroid disease 17 Negative 0.3895 
Sample 91 Pre-diabetes 53 Positive 1.1785 
Sample 92 Pre-diabetes 69 Positive 0.5720 
Sample 93 Pre-diabetes ---- Positive 0.9810 
Sample 94 Pre-diabetes 34 Positive 0.6205 
Sample 95 Rheumatoid arthritis 56 Positive 0.3550 
Sample 96 Thyroid disease 46 Negative 0.4125 
Sample 97 Thyroid disease 52 Positive 0.5265 
Sample 98 Thyroid disease 29 Negative 0.6170 
Sample 99 Thyroid disease 30 Negative 0.2835 
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